Skip to content
BillRazor
Generic

DESOXIMETASONE 0.05% GEL

DESOXIMETASONE 0.05% GEL, a generic topical corticosteroid, has a Medicare acquisition cost of $3.67, though hospitals typically charge patients significantly more than this benchmark price.

By David Park , Healthcare Cost Researcher · ·
Data from CMS files published FY 2024 CMS IPPS. Refreshed weekly.
About the analyst

David Park researches procedure pricing and insurance reimbursement patterns at BillRazor Research. He specializes in cost comparison across care settings and metropolitan areas. Expertise: procedure pricing, insurance reimbursement, cost comparison.

NADAC acquisition cost data
CMS drug pricing benchmarks
Updated 2026-04-03
Drug acquisition cost — DESOXIMETASONE 0.05% GEL
NADAC cost$3.67 per unit
Hospital charges for this drug vary — typically 3–8x the acquisition cost. No observed hospital charge data is available for this specific drug.
$3.67
NADAC acquisition cost
GEL
Dosage form
TOPICAL
Route

Desoximetasone 0.05% gel is a topical corticosteroid prescribed for inflammatory skin conditions like eczema and dermatitis. This generic formulation typically generates lower reimbursement rates compared to brand-name alternatives, with Medicare coverage requiring prior authorization in some regions.

Check your bill amount
Enter the charge for DESOXIMETASONE 0.05% GEL from your bill to compare against the NADAC acquisition cost.
$

No credit card required. Results in 60 seconds.

Research suggests 49–80% of hospital bills contain errors. Our system checks every line item against Medicare benchmarks.
Rates shown are from the 2026 Medicare Physician Fee Schedule and CMS IPPS. BillRazor compares your bill against these data sources. See how it works →

Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.

What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.

Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.

Upload your bill — free instant analysis